Bortezomib inhibits gastric carcinoma HGC-27 cells through the phospho-Jun N-terminal kinase (p-JNK) pathway in vitro

Gene

Volumn 559, Issue 2, 2015, Pages 164-171

  Zhang, BeiLi ^a   Gu, Yan ^a  

^a SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

Author keywords

Bortezomib; Gastric cancer; HGC 27 cells; Phospho Jun N terminal kinase

Indexed keywords

ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; BORTEZOMIB; CASPASE 3; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; PROTEIN BAX; PROTEIN BCL 2; STRESS ACTIVATED PROTEIN KINASE; ANTINEOPLASTIC AGENT; BORONIC ACID DERIVATIVE; PYRAZINE DERIVATIVE;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME INHIBITION; GASTRIC CANCER CELL LINE; HGC 27 CELL LINE; HUMAN; HUMAN CELL; IN VITRO STUDY; MTT ASSAY; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH CARCINOMA; CELL SHAPE; CELL SURVIVAL; DRUG EFFECTS; METABOLISM; SIGNAL TRANSDUCTION; STOMACH TUMOR; TUMOR CELL LINE; UPREGULATION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BORONIC ACIDS; CELL LINE, TUMOR; CELL SHAPE; CELL SURVIVAL; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MAP KINASE SIGNALING SYSTEM; PYRAZINES; STOMACH NEOPLASMS; UP-REGULATION;

EID: 84922359367     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2015.01.035     Document Type: Article

References (31)

1. Adams J.M., Cory S. The Bcl-2 protein family: arbiters of cell survival. Science 1998, 281:1322-1326.
2. Chen Y., Yang S.-H., Hueng D.-Y., Syu J.-P., Liao C.-C., Wu Y.-C. Cordycepin induces apoptosis of C6 glioma cells through the adenosine 2A receptor-p53-caspase-7-PARP pathway. Chem. Biol. Interact. 2014, 216:17-25.
3. De P., Sun Y.L., Carlson J.H., Friedman L.S., Leyland-Jones B.R., Dey N. Doubling down on the PI3K-AKT-mTOR Pathway enhances the antitumor efficacy of PARP inhibitor in triple negative breast cancer model beyond BRCA-ness. Neoplasia 2014, 16(1):43-72. (W16-W19).
4. Decker P., Muller S. Modulating poly (ADP-ribose) polymerase activity: potential for the prevention and therapy of pathogenic situations involving DNA damage and oxidative stress. Curr. Pharm. Biotechnol. 2002, 3:275-283.
5. Dou Q.P., Goldfarb R.H. Bortezomib (millennium pharmaceuticals). IDrugs 2002, 5:828-834.
6. Fahy B.N., Schlieman M.G., Mortenson M.M., Virudachalam S., Bold R.J. Targeting BCL-2 overexpression in various human malignancies through NF-kappaB inhibition by the proteasome inhibitor bortezomib. Cancer Chemother. Pharmacol. 2005, 56:46-54.
7. Fribley A., Zeng Q., Wang C.Y. Proteasome inhibitor PS-341 induces apoptosis through induction of endoplasmic reticulum stress-reactive oxygen species in head and neck squamous cell carcinoma cells. Mol. Cell. Biol. 2004, 24:9695-9704.
8. Huang C., Jacobson K., Schaller M.D. MAP kinases and cell migration. J. Cell Sci. 2004, 117:4619-4628.
9. Ishihara R. Infrared endoscopy in the diagnosis and treatment of early gastric cancer. Endoscopy 2010, 42:672-676.
10. Kane R.C., Farrell A.T., Sridhara R., Pazdur R. United States Food and Drug Administration approval summary: bortezomib for the treatment of progressive multiple myeloma after one prior therapy. Clin. Cancer Res. 2006, 12:2955-2960.
11. Kang S.A., Park H.J., Kim M.J., Lee S.Y., Han S.W., Leem K.H. Citri Reticulatae Viride Pericarpium extract induced apoptosis in SNU-C4, human colon cancer cells. J. Ethnopharmacol. 2005, 97:231-235.
12. Kang N., Zhang J.H., Qiu F., Tashiro S., Onodera S., Ikejima T. Inhibition of EGFR signaling augments oridonin-induced apoptosis in human laryngeal cancer cells via enhancing oxidative stress coincident with activation of both the intrinsic and extrinsic apoptotic pathways. Cancer Lett. 2010, 294:147-158.
13. Kim J., Kim C., Kim T.S., Bang S.I., Yang Y., Park H., et al. IL-18 enhances thrombospondin-1 production in human gastric cancer via JNK pathway. Biochem. Biophys. Res. Commun. 2006, 344:1284-1289.
14. Kyriakis J.M., Banerjee P., Nikolakaki E., Dai T., Rubie E.A., Ahmad M.F., Avruch J., Woodgett J.R. The stress-activated protein kinase subfamily of c-Jun kinases. Nature 1994, 369:156-160.
15. Liang B., Wang S., Zhu X.G., Yu Y.X., Cui Z.R., Yu Y.Z. Increased expression of mitogen-activated protein kinase and its upstream regulating signal in human gastric cancer. World J. Gastroenterol. 2005, 11:623-628.
16. Malilas W., Koh S.S., Srisuttee R., Boonying W., Cho I.R., Jeong C.S., Johnston R.N., Chung Y.H. Cancer upregulated gene 2, a novel oncogene, confers resistance to oncolytic vesicular stomatitis virus through STAT1-OASL2 signaling. Cancer Gene Ther. 2013, 20:125-132.
17. Meusser B., Hirsch C., Jarosch E., Sommer T. ERAD: the long road to destruction. Nat. Cell Biol. 2005, 7:766-772.
18. Molinari M. Cell cycle checkpoints and their inactivation in human cancer. Cell Prolif. 2000, 33:261-274.
19. Muscolini M., Cianfrocca R., Sajeva A., et al. Trichostatin A up-regulates p73 and induces Bax-dependent apoptosis in cisplatin-resistant ovarian cancer cells. Mol. Cancer Ther. 2008, 7:1410-1419.
20. Nawrocki S.T., Carew J.S., Dunner K., Boise L.H., Chiao P.J., Huang P., Abbruzzese J.L., McConkey D.J. Bortezomib inhibits PKR-like endoplasmic reticulum (ER) kinase and induces apoptosis via ER stress in human pancreatic cancer cells. Cancer Res. 2005, 65:11510-11519.
21. Neugut A.I., Hayek M., Howe G. Epidemiology of gastric cancer. Semin. Oncol. 1996, 23:281-291.
22. Ortiz-Sánchez E., Daniels T.R., Helguera G., Martinez-Maza O., Bonavida B., Penichet M.L. Enhanced cytotoxicity of an anti-transferrin receptor IgG3-avidin fusion protein in combination with gambogic acid against human malignant hematopoietic cells: functional relevance of iron, the receptor, and reactive oxygen species. Leukemia 2009, 23:59-70.
23. Siegel C., McCullough L.D. NAD+ depletion or PAR polymer formation: which plays the role of executioner in ischaemic cell death?. Acta Physiol. (Oxf.) 2011, 203:225-234.
24. Sun W.H., Zhu F., Chen G.S., Su H., Luo C., Zhao Q.S., Zhang Y., Shao Y., Sun J., Zhou S.M., Ding G.X., Cheng Y.L. Blockade of cholecystokinin-2 receptor and cyclooxygenase-2 synergistically induces cell apoptosis, and inhibits the proliferation of human gastric cancer cells in vitro. Cancer Lett. 2008, 263:302-311.
25. Sun W.H., Chen G.S., Ou X.L., Yang Y., Luo C., Zhang Y., Shao Y., Xu H.C., Xiao B., Xue Y.P., Zhou S.M., Zhao Q.S., Ding G.X. Inhibition of COX-2 and activation of peroxisome proliferator-activated receptor gamma synergistically inhibits proliferation and induces apoptosis of human pancreatic carcinoma cells. Cancer Lett. 2009, 275:247-255.
26. Tanizawa Y., Terashima M. Lymph node dissection in the resection of gastric cancer: review of existing evidence. Gastric Cancer 2010, 13:137-148.
27. Wang Y., Li Z., Zhang H., Jin H., Sun L., Dong H., et al. HIF-1alpha and HIF-2alpha correlate with migration and invasion in gastric cancer. Cancer Biol. Ther. 2010, 10:376-382.
28. Widmann C., Gibson S., Jarpe M.B., Johnson G.L. Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human. Physiol. Rev. 1999, 79:143-180.
29. Wu Y.L., Sun B., Zhang X.J., Wang S.N., He H.Y., Qiao M.M., et al. Growth inhibition and apoptosis induction of sulindac on human gastric cancer cells. World J. Gastroenterol. 2001, 7:796-800.
30. Xiao F., Liu B., Zhu Q.X. c-Jun N-terminal kinase is required for thermotherapy-induced apoptosis in human gastric cancer cells. World J. Gastroenterol. 2012, 18:7348-7356.
31. Yue T., Yin J., Li F., Li D., Du M. High glucose induces differentiation and adipogenesis in porcine muscle satellite cells via mTOR. BMB Rep. 2010, 43:140-145.